1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. VERICEL CORP
Vericel Corp XNAS: VCEL

Vericel Corp Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondroc...

Read More
38.56 -2.17 (-5.33%)
38.79% Fall from 52W High
787.7K
XNAS Volume

XNAS 09 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Vericel Corp is on 14 Jan 2026 for the purpose of 44(th) Annual J.P. Morgan Healthcare Conference See details
Durability score
High Financial Strength
72.2 / 100
Valuation Score
Mid Valuation
37.2 / 100
Momentum Score
Technically Neutral
55.8 / 100
Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM
Analyst Price Target
55
1Yr Price target upside is 43%
7 analysts

22

S

8

W

6

O

0

T

SWOT Analysis

Vericel Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..